Gillessen, S. Et Al. 2023. Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022. European Urology , vol.83, no.3 , 267-293.

Gillessen, S., Bossi, A., Davis, I. D., de Bono, J., Fizazi, K., James, N. D., ... Mottet, N.(2023). Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022. European Urology , vol.83, no.3, 267-293.

Gillessen, Silke Et Al. "Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022," European Urology , vol.83, no.3, 267-293, 2023

Gillessen, Silke Et Al. "Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022." European Urology , vol.83, no.3, pp.267-293, 2023

Gillessen, S. Et Al. (2023) . "Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022." European Urology , vol.83, no.3, pp.267-293.

@article{article, author={Silke Gillessen Et Al. }, title={Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022}, journal={European Urology}, year=2023, pages={267-293} }